Rapid Graft

Zurich, Switzerland Founded: 2017 • Age: 9 yrs
Split-skin grafts are developed for chronic wound treatment.
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 2 Services tracked
Competitors 10 Brand Intelligence

About Rapid Graft

Rapid Graft is a company based in Zurich (Switzerland) founded in 2017 by Blaise Jacholkowski, Manuel Ghilardi, and Marcel Gort. Rapid Graft offers products and services including Skin Grafts and Rapid Graft System. Rapid Graft operates in a competitive market with competitors including MiMedx Group, Reprise Biomedical, pacifymedical, Hans Biomed and RestoreFlow Allografts, among others.

  • Headquarter Zurich, Switzerland
  • Founders Blaise Jacholkowski, Manuel Ghilardi, Marcel Gort
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Rapid Graft

Rapid Graft offers a comprehensive portfolio of products and services, including Skin Grafts and Rapid Graft System.

Product name locked
Category locked
Primary

Standardized small grafts for convenient surgical skin repair.

Product name locked
Category locked
Locked

Platform for producing consistent skin grafts efficiently.

Funding Insights of Rapid Graft

Investors in Rapid Graft

Rapid Graft has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include MassChallenge.

All
Venture Fund
Investor Description Founded Year Domain Location
Early-stage entrepreneurs are accelerated through MassChallenge's program.
Locked Locked Locked
Premium access

Investor details for Rapid Graft

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Rapid Graft

Investments
Premium access

Investment portfolio details for Rapid Graft

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Rapid Graft

Premium access

Detailed financials for Rapid Graft

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Rapid Graft Comparisons

Rapid Graft Primary company
Description
Split-skin grafts are developed for chronic wound treatment.
Location
Zurich, Switzerland
Founded Year
2017
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Rapid Graft

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Rapid Graft

Rapid Graft operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiMedx Group, Reprise Biomedical, pacifymedical, Hans Biomed and RestoreFlow Allografts, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
Locked Locked Locked
Developer of surgical mesh for wound management
Locked Locked Locked
Skin-spraying devices for advanced wound care are developed and manufactured.
Locked Locked Locked
Allograft tissues, biomaterials, and skin cell treatments are developed.
Locked Locked Locked
Regenerative medicines from human tissues are developed for multiple diseases.
Premium access

Detailed competitors of Rapid Graft

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Rapid Graft

Premium access

Complete news archive for Rapid Graft

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rapid Graft

Rapid Graft was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Rapid Graft is headquartered in Zurich, Switzerland.

Marcel Gort is the current CEO of Rapid Graft. They have also founded this company.

Rapid Graft was founded in 2017 in Zurich, Switzerland, as a developer in the medical technology sector. Split-skin grafts are produced by the company to aid in the treatment of chronic wounds. Operations focus on advancing graft technologies for healthcare applications. Leadership is provided by co-founders including Marcel Gort as CEO, Blaise Jacholkowski, and Manuel Ghilardi as COO. The domain rapidgraft.ch is maintained for online presence.

Rapid Graft's top competitors include MiMedx Group, Reprise Biomedical and pacifymedical.

Rapid Graft offers Skin Grafts and Rapid Graft System.

Rapid Graft has 1 investor. Key investors include MassChallenge.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available